Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties
Béatrice Guardiola‐Lemaître, Christian de Bodinat, Philippe Delagrange, et al.
British Journal of Pharmacology (2014) Vol. 171, Iss. 15, pp. 3604-3619
Open Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

Melatonin receptors: molecular pharmacology and signalling in the context of system bias
Erika Cecon, Atsuro Oishi, Ralf Jockers
British Journal of Pharmacology (2017) Vol. 175, Iss. 16, pp. 3263-3280
Open Access | Times Cited: 233
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 205
Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus
Chelsea A. Vadnie, Colleen A. McClung
Neural Plasticity (2017) Vol. 2017, pp. 1-28
Open Access | Times Cited: 178
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Stefano Aringhieri, Marco Carli, Shivakumar Kolachalam, et al.
Pharmacology & Therapeutics (2018) Vol. 192, pp. 20-41
Closed Access | Times Cited: 177
Structural basis of ligand recognition at the human MT1 melatonin receptor
Benjamin Stauch, Linda C. Johansson, John D. McCorvy, et al.
Nature (2019) Vol. 569, Iss. 7755, pp. 284-288
Open Access | Times Cited: 168
Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
Mark J. Millan, Guy M. Goodwin, Andreas Meyer‐Lindenberg, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 5, pp. 599-656
Closed Access | Times Cited: 125
Chronobesity: role of the circadian system in the obesity epidemic
Jorien Laermans, Inge Depoortere
Obesity Reviews (2015) Vol. 17, Iss. 2, pp. 108-125
Closed Access | Times Cited: 115
Molecular aspects of depression: A review from neurobiology to treatment
Gustavo Roberto Villas Boas, Roseli Boerngen de Lacerda, Marina Meirelles Paes, et al.
European Journal of Pharmacology (2019) Vol. 851, pp. 99-121
Closed Access | Times Cited: 113
New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders
Giuseppe Di Giovanni, Philippe De Deurwaerdère
Pharmacology & Therapeutics (2015) Vol. 157, pp. 125-162
Closed Access | Times Cited: 102
Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
Elena Urrestarazu, Jorge Iriarte
Nature and Science of Sleep (2016), pp. 21-21
Open Access | Times Cited: 102
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
Roger S. McIntyre, Henrik Loft, Michael Cronquist Christensen
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 575-585
Open Access | Times Cited: 59
Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
Omnia Kutkat, Yassmin Moatasim, Ahmed A. Al‐Karmalawy, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression
Domenico De Berardis, Michele Fornaro, Nicola Serroni, et al.
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 1, pp. 1111-1130
Open Access | Times Cited: 70
Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus
Yanxia Lu, Cyrus S. H. Ho, Roger S. McIntyre, et al.
Life Sciences (2018) Vol. 210, pp. 177-184
Closed Access | Times Cited: 68
Circadian insights into the biology of depression: Symptoms, treatments and animal models
Jorge Mendoza
Behavioural Brain Research (2019) Vol. 376, pp. 112186-112186
Open Access | Times Cited: 57
Agomelatine for depression: expanding the horizons?
Trevor R. Norman, James Olver
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 6, pp. 647-656
Closed Access | Times Cited: 56
Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action
Mark J. Millan
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 28
New insights on the antidepressant discontinuation syndrome
Brian H. Harvey, Francois Naudé Slabbert
Human Psychopharmacology Clinical and Experimental (2014) Vol. 29, Iss. 6, pp. 503-516
Closed Access | Times Cited: 54
Mood‐related central and peripheral clocks
Kyle D. Ketchesin, Darius D. Becker‐Krail, Colleen A. McClung
European Journal of Neuroscience (2018) Vol. 51, Iss. 1, pp. 326-345
Open Access | Times Cited: 50
Structural insights into melatonin receptors
Benjamin Stauch, Linda C. Johansson, Vadim Cherezov
FEBS Journal (2019) Vol. 287, Iss. 8, pp. 1496-1510
Open Access | Times Cited: 50
The Impact of Circadian Rhythms on the Development of Depression
Xinzhe Li
Theoretical and Natural Science (2025) Vol. 75, Iss. 1, pp. 34-40
Closed Access
Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trial
Yongqin Ju, Wenwen Ou, Hao Chen, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Agomelatine with cognitive behavioral therapy reduces insomnia severity index and subjective units of distress scores than initial-dose clonazepam in moderate to severe insomnia patients: A quasi-experimental study
Kousalya Prabahar, A Ravikumar, Abiramy Jeyabalan, et al.
Pharmacology Biochemistry and Behavior (2025), pp. 174003-174003
Closed Access
The protective role of melatonin and agomelatine against oxidative stress following laparoscopic ovariectomy in dogs
Shahrzad Azizi, Hossein Kazemi Mehrjerdi, Mahdieh Zaeemi
BMC Veterinary Research (2025) Vol. 21, Iss. 1
Open Access
Social isolation rearing-induced anxiety and response to agomelatine in male and female rats: Role of corticosterone, oxytocin, and vasopressin
Brian H. Harvey, Wilmie Regenass, Walter Dreyer, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 5, pp. 640-646
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top